Patients with eosinophilic granulomatosis with polyangiitis frequently experienced gastrointestinal manifestations, including hemorrhages, obstructions, and perforations. Gastrointestinal (GI ...

Gastrointestinal (GI) involvement is a common and potentially severe manifestation of eosinophilic granulomatosis with polyangiitis (EGPA), according to study results published in Arthritis Research & ...

GlaxoSmithKline’s Nucala (mepolizumab) has gained a new FDA approval for the rare autoimmune disease eosinophilic granulomatosis with polyangiitis (EGPA). Nucala, an interleukin-5 (IL-5 ...

为解决昆虫毒液过敏和 EGPA 治疗问题，研究人员开展相关研究，获新疗法成果，意义重大。 在春光明媚的时节，花丛中飞舞的蜜蜂、黄蜂给大自然增添了生机，可对于一些人来说，这些小昆虫却隐藏着巨大的威胁。昆虫毒液过敏可能引发严重甚至危及生命的反应 ...

GSK’s application is underpinned by the positive outcomes from the Phase III MATINEE trial, which demonstrated a significant ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Nucala is approved for four indications, namely severe eosinophilic asthma CRSwNP, eosinophilic granulomatosis with polyangiitis (EGPA), and hypereosinophilic syndrome (HES), and has also shown ...

Mepolizumab is intended for individuals aged six years and above with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (EGPA), and for adults who have no adequate ...

Various showbiz personalities expressed their support for former host-actress Kris Aquino who praised her youngest ...